Qiagen, Ventana settle dispute
This article was originally published in The Gray Sheet
Executive Summary
Qiagen (formerly Digene) and Ventana Medical settle their dispute over patents related to human papillomavirus tests Dec. 15. Ventana will pay an undisclosed cash amount. Qiagen is involved in ongoing disputes with other HPV test developers Third Wave Technologies and Roche (1"The Gray Sheet" Oct. 22, 2007, p. 22)